Overview

A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to evaluate safety, tolerability, treatment outcomes, appropriate use and pattern of paliperidone palmitate usage in participants with schizophrenia in the hospital setting.
Details
Lead Sponsor:
Janssen-Cilag International NV
Treatments:
Paliperidone Palmitate